Recent Transactions

27-May-25
$100 million
United States flag
Target: 

Emergency Care Partners

flag not available

Advised Emergency Care Partners (“ECP”), a leading provider of emergency department management services and its majority owner Varsity Healthcare Partners (“VHP”) on a growth recapitalization transaction, inclusive of a $100 million preferred equity investment led by MidOcean Partners (“MidOcean”)

13-May-25
Pending
Undisclosed
Australia flag
Target: 

Seagrass Boutique Hospitality Group

Japan flag
Acquiror: 
Colowide Co., Ltd

Advising Seagrass Boutique Hospitality Group (“Seagrass”), a Crescent Capital Partners portfolio company, on its sale to Tokyo Stock Exchange listed Colowide Co., Ltd. Seagrass is one of Australia and the UAE’s largest and most successful premium steak-based restaurant groups

08-May-25
Undisclosed
United Kingdom flag
Target: 

German Doner Kebab ("GDK")

United Kingdom flag
Acquiror: 
True

Advised Hero Brands on the strategic investment in GDK by True. GDK is a leading Middle Eastern quick-service restaurant brand, with over 145 franchised locations in the UK and 170 globally, including the US, Canada, Sweden and the Middle East

05-May-25
Pending
~$10 billion
United States flag
Target: 

Skechers U.S.A., Inc.

United States flag
Acquiror: 
3G Capital

Advising Skechers, the third largest footwear company in the world, on its sale to 3G Capital

28-Mar-25
Pending
$100 million
United Kingdom flag
Target: 

UK High Street business of WH Smith PLC

United Kingdom flag
Acquiror: 
Modella Capital

Advising WH Smith PLC, one of the UK’s leading retailers, on the sale of its UK High Street business

11-Feb-25
$320 million (AUD value)
Australia flag
Target: 

Pacific Smiles Group

Australia flag
Acquiror: 
Genesis Capital

Advised Pacific Smiles Group Limited, one of Australia’s leading and fastest growing dental service organisations, on its response to multiple private equity proposals and ultimate sale to Genesis Capital by way of off-market takeover

04-Feb-25
Pending
$1.1 billion
United States flag
Target: 

PRISM Vision Group

United States flag
Acquiror: 
McKesson Corporation

Advising PRISM Vision Group, a leading medical eye care services company, on its majority stake sale to McKesson Corporation, a diversified healthcare services and distribution leader

28-Jan-25
$219 million
United States flag
Target: 

The Container Store, Inc.

flag not available

Advised the Ad Hoc Group of Term Loan Lender to The Container Store on its Pre Packaged Chapter 11 Restructuring

27-Nov-24
$618 million
United States flag
Target: 

Empire Today

flag not available

Advised Empire Today, the largest and only national DTC provider of replacement hard surface flooring and carpet in the U.S., on its liability management transaction

13-Nov-24
Pending
Undisclosed
Germany flag
Target: 

Centogene GmbH

Italy flag
Acquiror: 
Charme Capital Partners

Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of  pharmaceutical solutions and diagnostic tests for rare diseases

01-Jul-24
Undisclosed
United States flag
Target: 

Medical Review Institute of America

United States flag
Acquiror: 
Parthenon Capital

Advised Medical Review Institute of America, a portfolio company of Summit Partners and a leading provider of outsourced utilization management and clinical review solutions to payors, on its strategic growth investment from Parthenon Capital

26-Jun-24
Pending
$630 million
Euro flag
Target: 

Haleon plc’s Nicotine Replacement Therapy Business (ex-US)

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advising Haleon plc on the sale of its global nicotine replacement therapy business (ex-US) to Dr. Reddy’s Laboratories

20-Jun-24
Pending
$1.8 billion
United States flag
Target: 

CP Kelco

United Kingdom flag
Acquiror: 
Tate & Lyle

Advising Tate & Lyle plc, a UK-listed specialty food and beverage ingredients company, on the acquisition of CP Kelco, a US-based provider of pectin, speciality gums and other nature-based ingredients, from J.M. Huber Corporation

08-May-24
$800 million
United States flag
Target: 

U.S. Acute Care Solutions

flag not available

Advised U.S. Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on the refinancing of its senior secured notes

01-May-24
Undisclosed
United States flag
Target: 

Functional Formularies

France flag
Acquiror: 
Danone

Advised Danone on its acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital

09-Apr-24
Undisclosed
United States flag
Target: 

Tegra’s Operating Entities in Honduras, El Salvador, and the U.S.

Korea flag
Acquiror: 
SAE-A Trading

Advising Tegra, a premier and leading near and onshore apparel manufacturer for sport, team, and performance apparel, on the sale of its operating entities in Honduras, El Salvador, and the U.S. to SAE-A Trading, a vertically integrated textile and apparel garment manufacturer

20-Feb-24
Pending
$185 million
Australia flag
Target: 

myHomecare Group

Australia flag
Acquiror: 
Australian Unity

Advising Australian Unity on its acquisition of myHomecare Group

16-Nov-23
~$400 million
United States flag
Target: 

Sonoma-Cutrer Vineyards (Brown-Forman)

United States flag
Acquiror: 
The Duckhorn Portfolio

Advised Brown-Forman, the largest American-owned spirits and wine company, on its sale of Sonoma-Cutrer Vineyards to The Duckhorn Portfolio

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

10-Aug-23
Undisclosed
United Kingdom flag
Target: 

Clinigen Ltd’s portfolio of Established Medicines

United Kingdom flag
Acquiror: 
CNX Therapeutics

Advised Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of a portfolio of Established Medicines to CNX Therapeutics, a UK-based European pharma company owned by Inflexion Partners

14-Jul-23
$674 million
U.S.A., U.K. flags
Target: 

Juice Plus+

flag not available

Advised Juice Plus+, a global health and wellness company in the direct selling space on a comprehensive recapitalization transaction

20-Jun-23
Pending
$595 million
United Kingdom flag
Target: 

Lookers Plc

Canada flag
Acquiror: 
Alpha Auto Group

Advising JerseyCo, the indirect Holdco of Alpha Auto Group, a Canadian automotive dealership group, on its acquisition of Lookers Plc, a leading UK automotive dealership group

01-Jun-23
Pending
Undisclosed
United States flag
Target: 

Interest in Joint Venture with CarepathRx Health System Solutions

United States flag
Acquiror: 
The Cigna Group

Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary

26-Apr-23
Pending
$127 million
Australia flag
Target: 

Marley Spoon business combination with 468 SPAC II

Germany flag
Acquiror: 
468 SPAC II SE

Advising Marley Spoon SE, an ASX listed global subscription-based meal kit provider, on its business combination agreement with 468 SPAC II, simultaneous capital raising and amendment to existing debt facilities

25-Apr-23
Pending
Undisclosed
United Kingdom flag
Target: 

Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®

United Kingdom flag
Acquiror: 
Advanz Pharma (UK)

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company

Pages

show all